Reduction in Use of cyproterone/ethinylestradiol (Diane-35 and Generics) After Risk Minimization Measures in the Netherlands, UK and Italy

Oct-20

Dermatology Endocrinology Gynecology and Obstetrics Pharmacoepidemiology Women's Health

AUTHORS : Fernie J.A. Penning-van Beest, PHARMO Institute for Drug Outcomes Research, Van Deventerlaan 30 /40, 3528 AE Utrecht, Netherlands – Email: pharmo@pharmo.nl

JOURNAL : Contraception

REFERENCE: 102(4):243-245

DOI : 10.1016/j.contraception.2020.05.010

Read more